TRIO Pharmaceuticals

Developer of a cancer immunotherapeutic antibody drug designed to generate immunogenic tumors. The company's drug offers dual-action tumor immunity-enhancing qualities aimed at treating cancers of hig...

Healthcare

San Francisco, CA, United States

Founded 2018

9 employees

Website

Valuation

$17M

Market implied

Share Price

N/A

Total Raised

$8.5M

Last Round

N/A

Investors

+10 other investors

View all 10 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock TRIO Pharmaceuticals's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required